Revolution Medicines CEO sells 86K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Revolution Medicines, Inc. (RVMD) reported that President and Chief Executive Officer Mark A. Goldsmith exercised options for 80,000 shares of common stock at an exercise price of $4.73 per share and, on the same date, sold an aggregate of 86,000 shares of common stock in multiple transactions at weighted average prices between $206.78 and $212.74, including sales through revocable trusts. The filing notes that these transactions were made pursuant to a Rule 10b5-1 trading plan adopted on May 22, 2026, and that his reported holdings include 182,938 restricted stock units.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
21 txns
Insider
GOLDSMITH MARK A
Role
See Remarks
Sold
86,000 shs ($17.99M)
Approx. gross sale proceeds
$17.99M
Approx. exercise cost
$378K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 80,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 80,000 | $4.73 | $378K |
| Sale | Common Stock F1, F3, F2 | 5,128 | $207.233 | $1.06M |
| Sale | Common Stock F1, F4, F2 | 24,917 | $208.3697 | $5.19M |
| Sale | Common Stock F1, F5, F2 | 35,938 | $209.2615 | $7.52M |
| Sale | Common Stock F1, F6, F2 | 3,813 | $210.2466 | $802K |
| Sale | Common Stock F1, F7, F2 | 6,583 | $211.3331 | $1.39M |
| Sale | Common Stock F1, F8, F2 | 3,621 | $212.0776 | $768K |
| Sale | Common Stock F9, F10 | 190 | $207.2454 | $39K |
| Sale | Common Stock F11, F10 | 951 | $208.3648 | $198K |
| Sale | Common Stock F12, F10 | 1,351 | $209.2812 | $283K |
| Sale | Common Stock F13, F10 | 136 | $210.4017 | $29K |
| Sale | Common Stock F14, F10 | 245 | $211.4651 | $52K |
| Sale | Common Stock F15, F10 | 127 | $212.0635 | $27K |
| Sale | Common Stock F9, F16 | 177 | $207.2515 | $37K |
| Sale | Common Stock F17, F16 | 937 | $208.3609 | $195K |
| Sale | Common Stock F18, F16 | 1,405 | $209.2664 | $294K |
| Sale | Common Stock F13, F16 | 126 | $210.403 | $27K |
| Sale | Common Stock F14, F16 | 229 | $211.4648 | $48K |
| Sale | Common Stock F15, F16 | 126 | $212.0641 | $27K |
| holding | Common Stock F19 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 344,085 contracts (Direct);
Common Stock — 267,330 shares (Direct);
Common Stock — 655,484 shares (Indirect, Trust)
Footnotes (19)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026.
- F2. Includes 182,938 restricted stock units.
- F3. This transaction was executed in multiple trades at prices ranging from $206.78 to $207.7750. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $207.79 to $208.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $208.80 to $209.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $209.80 to $210.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $210.81 to $211.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. This transaction was executed in multiple trades at prices ranging from $211.82 to $212.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F9. This transaction was executed in multiple trades at prices ranging from $206.78 to $207.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F10. Held by Jonathan Goldsmith Revocable Trust.
- F11. This transaction was executed in multiple trades at prices ranging from $207.84 to $208.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F12. This transaction was executed in multiple trades at prices ranging from $208.84 to $209.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F13. This transaction was executed in multiple trades at prices ranging from $209.87 to $210.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F14. This transaction was executed in multiple trades at prices ranging from $210.93 to $211.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F15. This transaction was executed in multiple trades at prices ranging from $212.00 to $212.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F16. Held by Rebecca Goldsmith Revocable Trust.
- F17. This transaction was executed in multiple trades at prices ranging from $207.80 to $208.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F18. This transaction was executed in multiple trades at prices ranging from $208.80 to $209.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F19. Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
Key Figures
Options exercised: 80,000 shares
Option exercise price: $4.73 per share
Shares sold: 86,000 shares
+5 more
8 metrics
Options exercised
80,000 shares
Stock option exercise into common stock on August 21, 2026
Option exercise price
$4.73 per share
Exercise price for 80,000-share stock option
Shares sold
86,000 shares
Aggregate common stock sold in reported transactions
Sale price range
$206.78–$212.74 per share
Ranges for weighted average prices in multiple sale trades
Restricted stock units
182,938 units
RSUs included in CEO’s reported holdings
Options remaining after exercise
344,085 options
Total derivative securities following the option transaction
Net shares sold
86,000 shares
Net buy/sell shares in transaction summary (net-sell)
Rule 10b5-1 plan adoption date
May 22, 2026
Adoption date of trading plan governing these transactions
Key Terms
Rule 10b5-1 trading plan, restricted stock units, weighted average price, revocable trust, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
restricted stock units financial
"Includes 182,938 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
revocable trust financial
"Held by Jonathan Goldsmith Revocable Trust."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did RVMD CEO Mark A. Goldsmith report on August 21, 2026?
Mark A. Goldsmith reported exercising options for 80,000 shares of Revolution Medicines common stock at $4.73 per share and selling an aggregate of 86,000 shares of common stock in multiple transactions at weighted average prices between $206.78 and $212.74.
Were the recent RVMD insider sales by the CEO made under a Rule 10b5-1 plan?
Yes. The transactions are described as made pursuant to a Rule 10b5-1 trading plan adopted by Mark A. Goldsmith on May 22, 2026, indicating the trades were pre-arranged under that plan.
What option exercise did the RVMD CEO report in this Form 4?
He reported exercising a stock option for 80,000 shares of Revolution Medicines common stock at an exercise price of $4.73 per share. The option had an original exercise date of August 9, 2023 and an expiration date of August 8, 2029.
At what prices were the RVMD CEO’s sales executed in this filing?
The reported common stock sales were executed at weighted average prices ranging from about $206.78 to $212.74 per share, with individual trades within specified price ranges described in the footnotes.
What portion of the RVMD CEO’s reported holdings consists of restricted stock units?
A footnote states that the CEO’s reported holdings include 182,938 restricted stock units, which are part of his overall reported equity position.
AI-generated analysis. How Rhea-AI works. Not financial advice.
